$PBH News

Prestige Consumer Healthcare: Better Valuation, But Too Much Uncertainty To Buy

Canaccord Genuity Maintains Buy on Prestige Consumer, Lowers Price Target to $72

Oppenheimer Downgrades Prestige Consumer Healthcare (PBH)

Prestige Consumer Healthcare Inc. (PBH) Q4 2026 Earnings Call Transcript

Oppenheimer Downgrades Prestige Consumer to Perform

Prestige Consumer Healthcare Inc. 2026 Q4 - Results - Earnings Call Presentation

Transcript: Prestige Consumer Q4 2026 Earnings Conference Call

Prestige Consumer Sees FY2027 Adj EPS $4.42-$4.51 vs $4.79 Est; Sees Sales $1.100B-$1.121B vs $1.159B Est

Prestige Consumer Q4 Adj. EPS $1.23 Misses $1.39 Estimate, Sales $281.617M Miss $293.661M Estimate

Oppenheimer Maintains Outperform on Prestige Consumer, Lowers Price Target to $65

Prestige Consumer Healthcare Inc. (PBH) Breathe Right - M&A Call - Slideshow

Prestige Consumer Healthcare to Buy Breathe Right, Other Brands for $1.045 Billion

Prestige Consumer Healthcare: Adding A Prestigious Brand

Prestige Consumer Healthcare to Acquire Consumer Health, Wellness Brands Portfolio in $1.05 Billion Deal

Prestige Consumer to buy Breathe Right brand in $1.05 billion deal

Foundation Consumer Healthcare Sells Portion of Consumer Health Business

Prestige Consumer Healthcare Announces Agreement to Acquire Breathe Right®, the Leader in Nasal Strips

Prestige Consumer Healthcare To Acquire Breathe Right And Brand Portfolio For $1.045B With $200M Revenue And $95M EBITDA, Deal To Close In First Half Fiscal 2027

Prestige Consumer Healthcare To Acquire Breathe Right And Brand Portfolio For $1.045B With $200M Revenue And $95M EBITDA, Deal To Close In First Half Fiscal 2027

Premium Brands Q4 Earnings Call Highlights